A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis

Introduction: The standard therapy for American cutaneous leishmaniasis (ACL) is intravenous meglumine antimoniate (IV-MA). However, treatment interruptions due to adverse events (AEs) and non-adherence are frequent. Consequently, intralesional MA (IL-MA) was proposed. Objective: This study examined...

Полное описание

Библиографические подробности

Главные авторы:	Bruna Côrtes Rodrigues, Marina Freitas Ferreira, Daniel Holanda Barroso, Jorgeth Oliveira Carneiro da Motta, Carmen Déa Ribeiro de Paula, Cláudia Porto, Sofia Sales Martins, Ciro Martins Gomes, Raimunda Nonata Ribeiro Sampaio
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Elsevier 2020-12-01
Серии:	International Journal for Parasitology: Drugs and Drug Resistance
Предметы:	Cutaneous leishmaniasis New world leishmaniasis Intralesional therapy Intralesional antimonial N-methyl glucamine Pentavalent antimonial
Online-ссылка:	http://www.sciencedirect.com/science/article/pii/S2211320720300440
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!